Revive Therapeutics Ltd.
Revive Therapeutics Ltd.
Revive Therapeutics is a life sciences company focused on the research and development of therapeutics and diagnostics for infectious diseases and rare disorders, and it is prioritizing drug development efforts to take advantage of several regulatory incentives awarded by the FDA such as Emergency Use Authorization, Orphan Drug, Fast Track, and Breakthrough Therapy designations. Currently, the Company is exploring the use of Bucillamine for the potential treatment of public health medical emergencies and rare inflammatory disorders. Revive is also advancing the development of Psilocybin-based therapeutics through various programs. For more information visit www.ReviveThera.com.
Revive Therapeutics Ltd. (RVV)
Revive Therapeutics Ltd. (RVV)
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
| Bid Broker | Bid Size | Bid Price | Ask Price | Ask Size | Ask Broker |
|---|---|---|---|---|---|
| Desjardins Securities Inc. | 98,000 | 0.005 | 0.01 | 342,000 | TD Securities Inc. |
| RBC Capital Markets | 100,000 | 0.005 | 0.01 | 15,000 | Scotia Capital Inc. |
| RBC Capital Markets | 300,000 | 0.005 | 0.01 | 2,000 | CIBC World Markets Inc. |
| TD Securities Inc. | 58,000 | 0.005 | 0.01 | 297,000 | RBC Capital Markets |
| Anonymous | 600,000 | 0.005 | 0.01 | 5,000 | National Bank Financial Inc. |
| TD Securities Inc. | 100,000 | 0.005 | 0.01 | 5,000 | TD Securities Inc. |
| TD Securities Inc. | 1,000,000 | 0.005 | 0.01 | 5,000 | TD Securities Inc. |
| BMO Nesbitt Burns Inc. | 280,000 | 0.005 | 0.01 | 5,000 | TD Securities Inc. |
| TD Securities Inc. | 6,000 | 0.005 | 0.01 | 2,000 | Desjardins Securities Inc. |
| Research Capital Corporation | 2,000,000 | 0.005 | 0.01 | 250,000 | Desjardins Securities Inc. |
| Bid Broker | Bid Size | Bid Price | Ask Price | Ask Size | Ask Broker |
|---|---|---|---|---|---|
| Anonymous | 200,000 | 0.005 | 0.01 | 28,000 | Anonymous |
| Anonymous | 500,000 | 0.005 | 0.00 | 0 | |
| Anonymous | 600,000 | 0.005 | 0.00 | 0 | |
| Anonymous | 600,000 | 0.005 | 0.00 | 0 | |
| Anonymous | 600,000 | 0.005 | 0.00 | 0 | |
| Anonymous | 600,000 | 0.005 | 0.00 | 0 | |
| Virtu Canada Corp. | 1,000 | 0.005 | 0.00 | 0 | |
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 |
| Bid Count | Bid Size | Bid Price | Ask Price | Ask Size | Ask Count |
|---|---|---|---|---|---|
| 98 | 14,648,000 | 0.005 | 0.01 | 1,395,000 | 22 |
| 0 | 0 | 0.00 | 0.015 | 2,027,000 | 14 |
| 0 | 0 | 0.00 | 0.02 | 101,000 | 5 |
| 0 | 0 | 0.00 | 0.025 | 191,000 | 4 |
| 0 | 0 | 0.00 | 0.03 | 201,000 | 3 |
| Bid Count | Bid Size | Bid Price | Ask Price | Ask Size | Ask Count |
|---|---|---|---|---|---|
| 7 | 3,101,000 | 0.005 | 0.01 | 28,000 | 1 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| Date/Time | Price | Change | Volume | Buyer | Seller | Venue |
|---|---|---|---|---|---|---|
| Mar 12, 18:51 | 0.01 | 0.00 | 15,000 | Questrade Inc. | Anonymous | CSE2 |
| Mar 12, 16:25 | 0.005 | -0.005 | 10,000 | Desjardins Securities Inc. | National Bank Financial Inc. | CSE |
| Mar 12, 13:53 | 0.005 | -0.005 | 15,000 | Anonymous | Questrade Inc. | CSE2 |
| Mar 12, 13:30 | 0.01 | 0.00 | 2,000 | TD Securities Inc. | TD Securities Inc. | CSE |
| Mar 11, 14:03 | 0.01 | 0.00 | 5,000 | National Bank Financial Inc. | National Bank Financial Inc. | CSE |
Company Info
SEDAR Information
Company Info
Capitalization
Bulletins
2019-0718 – New Listing - Revive Therapeutics Ltd. (RVV)
le 19 juillet/July 2019
The common shares of Revive Therapeutics Ltd. have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.
